PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

varenicline Side Effects

The reactions most often reported to the FDA for varenicline (also sold as Chantix), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

5,766
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2007 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of varenicline come from 5,766 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 5,766 reports to the FDA Adverse Event Reporting System (FAERS) for varenicline (Chantix): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

5,766

Reports Mentioning Death

65

1.1% of reports — not proof the medicine caused the death

Hospitalizations

469

8.1% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

SNEEZING
732
NAUSEA
558
VOMITING
381
DEPRESSION
349
HEADACHE
289
NASAL DISCOMFORT
260
PRODUCT DELIVERY MECHANISM ISSUE
252
RHINORRHOEA
226
NIGHTMARE
212
ABNORMAL DREAMS
210
SUICIDAL IDEATION
207
COUGH
196
INSOMNIA
188
EYE PAIN
181
THROAT IRRITATION
178
DIZZINESS
170
EPISTAXIS
169
ANXIETY
158
AGITATION
153

Who Reports Side Effects

Gender Distribution

Female 3,007 (58%)
Male 2,179 (42%)
Unknown 7

Age Distribution

0-17 23 (1%)
18-44 433 (14%)
45-64 1,668 (54%)
65-74 646 (21%)
75+ 323 (10%)

Reporting Trend by Year

2007 2025

Reactions in Death Reports

Top reactions reported in 65 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
COMPLETED SUICIDE 20
DEATH 19
TOXICITY TO VARIOUS AGENTS 11
ACCIDENTAL OVERDOSE 3
CARDIAC ARREST 3
FALL 3
PRODUCT PRESCRIBING ERROR 3
ACUTE KIDNEY INJURY 2
ACUTE RESPIRATORY FAILURE 2
AMNESIA 2
ATRIAL FIBRILLATION 2
BALANCE DISORDER 2
CARDIO-RESPIRATORY ARREST 2
HYPERKALAEMIA 2
INTENTIONAL OVERDOSE 2
INTENTIONAL SELF-INJURY 2
ABDOMINAL DISTENSION 1
ACCIDENT 1
ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD 1

Reactions in Hospitalization Reports

Top reactions in 469 reports where hospitalization was an outcome.

Reaction Reports
DRUG INTERACTION 47
SUICIDAL IDEATION 39
VOMITING 39
DEPRESSION 35
DRUG-INDUCED LIVER INJURY 32
HEPATIC CIRRHOSIS 32
ANXIETY 31
HEPATOTOXICITY 31
HEPATIC ENCEPHALOPATHY 29
HEPATIC NECROSIS 29
PNEUMONIA 29
SUICIDE ATTEMPT 29
DYSPNOEA 28
NAUSEA 28
FATIGUE 27
CONFUSIONAL STATE 25
DIZZINESS 24
ASTHENIA 23
DIARRHOEA 22
FALL 22

Compare varenicline vs acamprosate →

What the FAERS Data Reveals About varenicline Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 5,766 voluntary reports linked to varenicline and its brand equivalents (Chantix), spanning 2007 through 2025. Of those, 65 (1.1%) listed death as an outcome and 469 (8.1%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 58% were female and 42% male; age distribution skews toward 45-64, with 1,668 reports in that bracket. The single most reported reaction is sneezing with 732 submissions, followed by nausea and vomiting.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.